Dr. Yong Poovorawan, head of the Centre of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, says that there is no need for a person who has…
Read More
Dr. Yong Poovorawan, head of the Centre of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, says that there is no need for a person who has…
Read More
From Thursday (September 1), COVID-19 patients can buy prescription antiviral medicines from pharmacies, as authorities ease access to weapons against the virus. “Health agencies are offering easier access to these…
Read More
Although COVID-19 patients have the option of being treated at private hospitals, health authorities still insist that doctors only prescribe antiviral drugs according to Medical Services Department (MDS) guidelines. Other…
Read More
The 8-bed ICU for severe COVID-19 cases requiring ventilators and the 30-bed cohort ward at the Bangkok Metropolitan Administration (BMA)’s General Hospital, also known as Klang Hospital, is now fully…
Read More
An 82-year-old bed-ridden patient has died at home, about a week after she was found to be infected with COVID-19. She did not develop any typical symptoms and a hospital…
Read More
The Ministry of Public Health has asked the Government Pharmaceutical Organization (GPO) for an additional 75 million Favipiravir and Molnupiravir anti-viral medicines, as it anticipates a surge in COVID-19 infections…
Read More
The Thai Department of Medical Services took delivery of two million capsules, or 50,000 courses, of Molnupiravir anti-viral medicine today (Friday) from Merck and Ridgeback Biotherapeutics, the joint developers and…
Read More
Thailand’s Medical Services Department signed a 500-million baht deal with MSD (Thailand) today (Thursday) to buy 50,000 courses of Merck’s Molnupiravir (Lagevrio) oral anti-viral medication for the treatment of COVID-19…
Read More
Thailand’s cabinet on Tuesday approved the planned purchase of Merck’s Mulnupiravir COVID-19 anti-viral drug, with a budget of 500 million Baht set for 50,000 courses of the drug, amounting to…
Read More
Thailand is not eligible to produce a generic version of Merck’s Molnupiravir anti-viral drug, which is shown to reduce hospitalisations and deaths among COVID-19 patients by 50%, because it is…
Read MoreCommon sense, whether it’s humanitarian or economic, dictates that if the world has found a drug that can make the coronavirus a lot less scary, the treatment should be made…
Read More
Thailand’s Centre for COVID-19 Situation Administration (CCSA) today (Thursday) approved the Public Health Ministry’s proposal to procure 50,000 courses of the anti-viral Molnupiravir drug, made by US pharmaceutical company Merck. …
Read More
The Ministry of Public Health is to seek approval from the Thai cabinet for the procurement of 200,000 courses of the Molnupiravir oral anti-viral medicine, using money from the Central…
Read MorePage 1 of 1